Advances

NewYork-Presbyterian

Advances in Cardiology, Interventional Cardiology, and Cardiothoracic Surgery

Top-ranked for the last 16 years, our cardiac program is led by the country’s most experienced and respected physicians and surgeons.

With 3 dedicated heart centers and a team at the forefront of medical innovation and research, our cardiac services make us the leading program in the nation for the treatment of structural heart/aortic, heart failure, and vascular disorders.

image of innovations report cover

Outcomes Report for Cardiovascular Services

The Report on Clinical and Scientific Innovations in Cardiovascular Services highlights the work of NewYork-Presbyterian physicians and scientists in heart failure and transplant, structural heart disease, aortic disease, and vascular disease, including recent progress in transcatheter, endovascular, and surgical procedures.

image of Heart failure axial CT scan

Advanced Heart Failure: Pursuing Progress on Many Fronts

From the latest medical therapies to ventricular assist devices and heart transplantation, NewYork-Presbyterian’s cardiologists and surgeons offer the most advanced medical and surgical options to patients who have many forms of advanced cardiac disease.

image of AccuCinch for treatment of heart failure

Extending the Reach of Transcatheter Therapies

With the great successes of TAVR, transcatheter therapies are emerging for other types of structural heart disease, including aortic regurgitation and disorders of the mitral and triscuspid valves. At the same time, studies continue underway to further enhance these procedures.

vector image of the heart

A Minimally Invasive Device for Total Aortic Arch Repair

Cardiac and vascular surgeons at NewYork-Presbyterian Hospital have come together for a groundbreaking trial to evaluate the first device for a complete aortic arch endovascular replacement available in the United States.

image of a normal ECG with arrhythmia elements

Novel Therapies in Electrophysiology

Patients with heart failure and patients with congenital heart disease can present with structural anomalies that make them poor candidates for traditional treatments for arrhythmias. At NewYork-Presbyterian Hospital, electro­physiologists are studying alternative methods for overcoming challenges to regulating heart rhythm in these patients.

vector image of CT of ascending aortic aneurysm

Clinical Considerations in Prosthetic Aortic Graft Replacement

Cardiothoracic surgeons and cardiologists at NewYork-Presbyterian Hospital provide insight into proximal aortic surgery, a lifesaving procedure for patients with ascending aortic aneurysms.

image of intrepid device

Transcatheter Trials Break New Ground

Promising catheter-based treatments under evaluation in multiple clinical trials are bringing help and hope to patients with severe mitral valve and tricuspid valve disease. At the forefront of these studies are the heart teams of NewYork-Presbyterian Hospital, where transcatheter therapies are in great demand.

vector illustration of a heart with a dilated left ventricle

Left Ventricular Remodeling and Its Reversal

Heart failure specialists at NewYork-Presbyterian Hospital examine the range of therapeutic options for heart failure caused by left ventricular remodeling. Their in-depth article in Structural Heart focuses on treatments that have been successful in preventing or reversing remodeling biological and physical approaches.

image of CTA whole aorta with curve MPR technique showing abdominal aorta and left, right iliac artery showing aortic dissection

TAA Repair and Coronary Surgical Practices: Cardiac Surgeons Present Compelling Research

Cardiothoracic surgeons at NewYork-Presbyterian report on new approaches to address daunting complications with open thoracoabdominal aneurysm repair and the ongoing debate on the adoption of coronary surgery as a super specialty.

3D computed tomography reconstruction of the heart and aorta

Mitral Valve Disease: The Treatment Evolution Continues

NewYork-Presbyterian heart teams are spearheading the latest trials in transcatheter repair and replacement to minimize the risks and maximize the outcomes for patients with complex mitral valve disease.

Transcatheter biological aortic valve replacement, while being monitored with a transesophageal echocardiogram

At #4 in the Nation, Elevating Cardiac Care Continues

NewYork-Presbyterian/Columbia University Irving Medical Center’s renowned cardiology and cardiac surgery program is advancing the field through our groundbreaking work in TAVR, adult congenital heart disease, sports cardiology, and obestrical cardiology programs.

red vector illustration of the heart inside the body

Dr. Nir Uriel: Elevating Progress in Advanced Heart Failure

Dr. Nir Uriel, an internationally recognized leader in heart failure, mechanical circulatory support, and heart transplantation, will oversee heart failure programs at NewYork-Presbyterian’s campuses in Manhattan, Queens, Brooklyn, and Westchester.

blue vector illustration of heart

Noteworthy Progress in LVAD Therapy: The HeartMate3

The FDA approved the HeartMate 3 left ventricular assist device (LVAD) as a destination therapy for patients with advanced heart failure who are not eligible for transplant, as a life-long implant.

image of Dr. Evelyn M. Horn

Pursuing Progress in Pulmonary Hypertension

Among the largest programs in the world for pulmonary hypertension, the Pulmonary Hypertension Centers of NewYork-Presbyterian manage some of the most complicated and sickest patients with this rare, progressive cardiopulmonary disease.

image of MRI scans of a patient with mitral regurgitation

Mitral Valve Disease: Maximizing Outcomes with Teamwork and New Technology

Cardiologists, interventional cardiologists, and cardiac surgeons at NewYork-Presbyterian bring their expertise to bear in colla¬borations that allow the details of the patient’s disease to dictate the best treatment.

image of The Sentinel Cerebral Protection System in use

TAVR Branches Out: New Refinements, Broader Indications

In the years since the first transcatheter aortic valve replacement (TAVR) was performed, the interventional cardiologists and cardiac surgeons at NewYork-Presbyterian have made inroads in device technologies and patient selection.

image of Dr. Emile A. Bacha

Adult Congenital Heart Disease Comes of Age

With the number of adult congenital heart disease patients exceeding the number of pediatric aged patients, clinicians at the Congenital Heart Center of NewYork-Presbyterian Hospital are charged with providing care for this unique patient population.

Newsletters for Medical Professionals

2020 Issue 2

2020 Issue 1

2019 Issue 2

2019 Issue 1

2018 Issue 3

2018 Issue 2

2018 Issue 1

2017 Issue 1

  • TAVR Branches Out: New Refinements, Broader Indications

2016 Issue 3

Spring 2016

Summer 2015

November/December 2014

Fall 2013

Winter 2013

Fall 2012